Acute and Chronic Pain Processing in the Thalamocortical System of Humans and Animal Models

Neuroscience ◽  
2018 ◽  
Vol 387 ◽  
pp. 58-71 ◽  
Author(s):  
Alexander Groh ◽  
Patrik Krieger ◽  
Rebecca A. Mease ◽  
Luke Henderson
e-Neuroforum ◽  
2017 ◽  
Vol 23 (3) ◽  
Author(s):  
Alexander Groh ◽  
Rebecca Mease ◽  
Patrik Krieger

AbstractThe transduction of painful stimuli into the experience of pain involves several peripheral and central signaling pathways of the nervous system. The organization of these pathways parallels the main functions of pain: the assessment of noxious stimuli (where, what, how strong), and the negative emotion of unpleasantness. Multiple lines of evidence suggest that the thalamocortical (TC) system, which interprets ascending pain signals, has two main pathways which support these functions. We discuss the structural and functional findings that support the view that the lateral TC pathway is involved in discriminative assessment of pain, while the medial TC pathway gives rise to aversive emotions associated with pain. Our review focuses on acute pain, but we also discuss putative TC maladaptations in humans and animal models of pain that are thought to underlie pathological pain sensations.


2005 ◽  
Vol 10 (suppl a) ◽  
pp. 7A-14A ◽  
Author(s):  
ME Lynch

Modern pharmacology of cannabinoids began in 1964 with the isolation and partial synthesis of delta-9-tetrahydrocannabinol, the main psychoactive agent in herbal cannabis. Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pain; the presence of cannabinoid receptors in pain-processing areas of the brain, spinal cord and periphery; and evidence supporting endogenous modulation of pain systems by cannabinoids has provided support that cannabinoids exhibit significant potential as analgesics. The present article presents an overview of the preclinical science.


2018 ◽  
Author(s):  
B. Monteiro ◽  
M. Moreau ◽  
C. Otis ◽  
L. De Lorimier ◽  
J. Pelletier ◽  
...  

2004 ◽  
Vol 5 (3) ◽  
pp. S1
Author(s):  
G. Iannetti ◽  
L. Zambreanu ◽  
G. Cruccu ◽  
I. Tracey
Keyword(s):  

2018 ◽  
Vol 2018 ◽  
pp. 1-14 ◽  
Author(s):  
Fausto Salaffi ◽  
Giovanni Giacobazzi ◽  
Marco Di Carlo

Chronic pain is nowadays considered not only the mainstay symptom of rheumatic diseases but also “a disease itself.” Pain is a multidimensional phenomenon, and in inflammatory arthritis, it derives from multiple mechanisms, involving both synovitis (release of a great number of cytokines) and peripheral and central pain-processing mechanisms (sensitization). In the last years, the JAK-STAT pathway has been recognized as a pivotal component both in the inflammatory process and in pain amplification in the central nervous system. This paper provides a summary on pain in inflammatory arthritis, from pathogenesis to clinimetric instruments and treatment, with a focus on the JAK-STAT pathway.


1997 ◽  
Vol 20 (3) ◽  
pp. 468-469
Author(s):  
Laszlo A. Urban

Although clinical studies and animal models seem to establish an important role for the sympathetic nervous system in many forms of neuropathic and inflammatory pain, there is an ongoing debate on the classification of pain syndromes with sympathetic components. The confusion originates from several sources: failure to acknowledge that the pathomechanism of chronic pain can change during the progress of the disease, which is now strongly underlined by experimental data from suitable animal models. Neuropathic pain is a vaguely defined collection of pain syndromes which includes painful conditions with diverse and largely unknown patho-mechanisms. Clinical diagnosis is difficult and well designed, placebo controlled sympathectomy is rarely performed. [blumberg et al.]


2004 ◽  
Vol 5 (3) ◽  
pp. S15 ◽  
Author(s):  
E. Sloane ◽  
S. Langer ◽  
E. Milligan ◽  
J. Wieseler-Frank ◽  
J. Mahoney ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document